Stockscreener 앱 받기
37.60
0.62%
0.23
시간 외 거래:
37.60
전일 마감가:
$37.37
열려 있는:
$37.305
하루 거래량:
679.51K
Relative Volume:
0.33
시가총액:
$5.97B
수익:
$264.79M
순이익/손실:
$-14.36M
주가수익비율:
-341.82
EPS:
-0.11
순현금흐름:
$-28.11M
1주 성능:
-3.19%
1개월 성능:
+2.84%
6개월 성능:
+29.48%
1년 성능:
+85.50%
1일 변동 폭
$37.21
$37.63
1주일 범위
$36.91
$39.73
52주 변동 폭
$16.65
$46.48
TG테라퓨틱스사 Stock (TGTX) Company Profile
명칭
Tg Therapeutics Inc
전화
(212) 554-4484
주소
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
TGTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
37.60 | 5.93B | 264.79M | -14.36M | -28.11M | -0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
TG테라퓨틱스사 Stock (TGTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2024-10-29 | 개시 | TD Cowen | Buy |
| 2023-08-02 | 업그레이드 | Goldman | Sell → Neutral |
| 2023-06-26 | 재개 | Jefferies | Buy |
| 2022-05-20 | 개시 | BofA Securities | Underperform |
| 2022-02-23 | 재확인 | B. Riley Securities | Buy |
| 2021-11-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-04-20 | 개시 | Goldman | Neutral |
| 2021-04-19 | 재확인 | H.C. Wainwright | Buy |
| 2020-09-01 | 개시 | JP Morgan | Overweight |
| 2020-08-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-05 | 개시 | Evercore ISI | Outperform |
| 2020-01-17 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-27 | 재개 | B. Riley FBR | Buy |
| 2019-02-06 | 재개 | Jefferies | Buy |
| 2018-09-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | 재개 | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | 재개 | H.C. Wainwright | Buy |
| 2017-04-25 | 개시 | Jefferies | Buy |
| 2017-03-06 | 재확인 | FBR & Co. | Outperform |
| 2016-10-06 | 재개 | Brean Capital | Buy |
| 2016-05-27 | 개시 | SunTrust | Buy |
| 2015-12-01 | 개시 | FBR Capital | Outperform |
| 2015-09-09 | 개시 | Raymond James | Strong Buy |
| 2015-08-12 | 재개 | H.C. Wainwright | Buy |
| 2015-06-19 | 재확인 | Brean Capital | Buy |
| 2014-12-11 | 재확인 | ROTH Capital | Buy |
| 2014-12-10 | 재확인 | ROTH Capital | Buy |
모두보기
TG테라퓨틱스사 주식(TGTX)의 최신 뉴스
TG Therapeutics Inc. Stock Analysis and ForecastTremendous growth potential - Autocar Professional
Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and TG Therapeutics (TGTX) - The Globe and Mail
Is TG Therapeutics Inc. a good long term investmentPhenomenal wealth increase - Autocar Professional
What analysts say about TG Therapeutics Inc. stockRapid wealth multiplication - jammulinksnews.com
What drives TG Therapeutics Inc. stock priceUnstoppable trading performance - Autocar Professional
How To Trade (TGTX) - news.stocktradersdaily.com
TG Therapeutics Joins Rank Of Stocks With RS Ratings Over 90 - MSN
A Note On TG Therapeutics, Inc.'s (NASDAQ:TGTX) ROE and Debt To Equity - simplywall.st
Goldman Sachs resumes TG Therapeutics stock coverage with Neutral rating By Investing.com - Investing.com Canada
We Think TG Therapeutics (NASDAQ:TGTX) Can Stay On Top Of Its Debt - 富途牛牛
Jim Cramer on TG Therapeutics: “You Should Buy the Stock” - MSN
Cramer's Lightning Round: TG Therapeutics is a buy - MSN
SHAREHOLDER COMPLAINT: Levi & Korsinsky LLP Files Case in U.S. District Court to Recover Losses Suffered By Investors in TG Therapeutics, Inc.Sets Lead Plaintiff Deadline of March 7, 2017 - ACCESS Newswire
14 Stocks Jim Cramer Recently Looked At - Insider Monkey
Jim Cramer on TG Therapeutics: "You Should Buy the Stock" - Yahoo Finance
Cramer Backs This Mining Giant After $1.6B Bet - Benzinga
TG Therapeutics: Cramer's Bullish Call Amid Clinical Pipeline Potential - AInvest
TG Therapeutics: Strong Execution Tempered By An Evolving Market (NASDAQ:TGTX) - Seeking Alpha
Long Term Trading Analysis for (TGTX) - news.stocktradersdaily.com
TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel (NASDAQ:TGTX) - Seeking Alpha
Exploring 3 High Growth Tech Stocks In The US Market - Yahoo Finance
Have Insiders Sold TG Therapeutics Shares Recently? - simplywall.st
Insider Selling: Yann Echelard Unloads $369K Of TG Therapeutics Stock - Nasdaq
Tg therapeutics director Yann Echelard sells $369,400 in stock - Investing.com Australia
(TGTX) Trading Advice - news.stocktradersdaily.com
Tg therapeutics director Yann Echelard sells $369,400 in stock By Investing.com - Investing.com Canada
TGTX Experiences Surge in Bullish Options Activity | TGTX Stock News - GuruFocus
Are Options Traders Betting on a Big Move in TG Therapeutics Stock? - Yahoo Finance
TG Therapeutics shareholders approve key proposals By Investing.com - Investing.com South Africa
TG Therapeutics Approves Key Proposals at Annual Meeting - TipRanks
TG Therapeutics shareholders approve key proposals - Investing.com
TG Therapeutics at Goldman Sachs Conference: Strategic Growth and Innovations - Investing.com Canada
Transcript : TG Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10 - marketscreener.com
GAMMA Investing LLC Purchases 176,573 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World
TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewswire
TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference | TGTX Stock News - GuruFocus
TG Therapeutics (NasdaqCM:TGTX) Stock Rises 13% In Last Month - Yahoo
Kalkine: TG Therapeutics Schedules Fireside Chat at Goldman Sachs Conference Amid FT100 Futures Focus - Kalkine Media
TG Therapeutics CEO Fireside Chat at Goldman's Premier Healthcare Conference: Key Updates Coming - Stock Titan
TG테라퓨틱스사 (TGTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.91%
0.25%
자본화:
|
볼륨(24시간):